Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
Bulios Fair Price
$14.64
24.8% upside
Trenutna cena
$11.73
Po podatkih Bulios Fair Price je delnica TNXP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Tonix Pharmaceuticals Holding Corp. (TNXP) is a biopharmaceutical company focused on developing drugs for the treatment of psychiatric and neurological disorders. Their main product candidates include medicines for the treatment of post-traumatic stress disorder (PTSD), fibromyalgia, and migraines. Tonix Pharmaceuticals focuses on utilizing advanced biotechnological methods and clinical trials to discover new treatment options for patients suffering from these conditions. The company is active in research and development and conducts clinical trials to assess the efficacy and safety of its medicinal products. Tonix Pharmaceuticals Holding Corp. (TNXP) shares could be suitable for investors looking for opportunities in the biopharmaceutical sector with a focus on the treatment of psychiatric and neurological disorders.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Seth Lederman
Employees
142
Headquarters
Berkeley Heights
Prihajajoči dogodki
Earnings
Upcoming earnings report